Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
J Virol. 2013 Dec;87(23):12794-804. doi: 10.1128/JVI.01160-13. Epub 2013 Sep 18.
Yellow fever virus (YFV) can induce acute, life-threatening disease that is a significant health burden in areas where yellow fever is endemic, but it is preventable through vaccination. The live attenuated 17D YFV strain induces responses characterized by neutralizing antibodies and strong T cell responses. This vaccine provides an excellent model for studying human immunity. While several studies have characterized YFV-specific antibody and CD8(+) T cell responses, less is known about YFV-specific CD4(+) T cells. Here we characterize the epitope specificity, functional attributes, and dynamics of YFV-specific T cell responses in vaccinated subjects by investigating peripheral blood mononuclear cells by using HLA-DR tetramers. A total of 112 epitopes restricted by seven common HLA-DRB1 alleles were identified. Epitopes were present within all YFV proteins, but the capsid, envelope, NS2a, and NS3 proteins had the highest epitope density. Antibody blocking demonstrated that the majority of YFV-specific T cells were HLA-DR restricted. Therefore, CD4(+) T cell responses could be effectively characterized with HLA-DR tetramers. Ex vivo tetramer analysis revealed that YFV-specific T cells persisted at frequencies ranging from 0 to 100 cells per million that are detectable years after vaccination. Longitudinal analysis indicated that YFV-specific CD4(+) T cells reached peak frequencies, often exceeding 250 cells per million, approximately 2 weeks after vaccination. As frequencies subsequently declined, YFV-specific cells regained CCR7 expression, indicating a shift from effector to central memory. Cells were typically CXCR3 positive, suggesting Th1 polarization, and produced gamma interferon and other cytokines after reactivation in vitro. Therefore, YFV elicits robust early effector CD4(+) T cell responses that contract, forming a detectable memory population.
黄热病毒(YFV)可引起急性、危及生命的疾病,在黄热病流行地区对健康造成严重负担,但可通过疫苗接种预防。减毒 17D YFV 株可诱导以中和抗体和强 T 细胞反应为特征的反应。该疫苗为研究人类免疫提供了极好的模型。虽然有几项研究描述了 YFV 特异性抗体和 CD8+T 细胞反应,但对 YFV 特异性 CD4+T 细胞的了解较少。在这里,我们通过使用 HLA-DR 四聚体研究外周血单核细胞,来描述接种疫苗的受试者中 YFV 特异性 T 细胞反应的表位特异性、功能属性和动态。总共鉴定了 112 个受七个常见 HLA-DRB1 等位基因限制的表位。表位存在于所有 YFV 蛋白中,但衣壳、包膜、NS2a 和 NS3 蛋白具有最高的表位密度。抗体阻断表明,大多数 YFV 特异性 T 细胞受 HLA-DR 限制。因此,CD4+T 细胞反应可以用 HLA-DR 四聚体有效地进行描述。体外四聚体分析显示,YFV 特异性 T 细胞的频率范围为每百万个细胞 0 至 100 个,可在接种疫苗后数年检测到。纵向分析表明,YFV 特异性 CD4+T 细胞在接种疫苗后约 2 周达到峰值频率,通常超过每百万个细胞 250 个。随着频率的随后下降,YFV 特异性细胞重新表达 CCR7,表明从效应细胞向中央记忆细胞转移。细胞通常为 CXCR3 阳性,表明 Th1 极化,并在体外重新激活后产生伽马干扰素和其他细胞因子。因此,YFV 可引发强烈的早期效应 CD4+T 细胞反应,这些反应会收缩,形成可检测的记忆群体。